The anti-atherosclerotic effect of tanshinone IIA is associated with the inhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression

Tanshinone IIA is one of the major diterpenes in Salvia miltiorrhiza. The inhibitory effect of Tanshinone IIA on atherosclerosis has been reported, but the underlying mechanism is not fully understood. The present study aimed to study the anti-atherosclerosis effect of Tanshinone IIA on the adhesion of monocytes to vascular endothelial cells and related mechanism. Results showed that Tanshinone IIA, at the concentrations without cytotoxic effect, dose-dependently inhibited the adhesion of THP-1 monocytes to the TNF-alpha-stimulated human vascular endothelial cells. The expressions of cell adhesion molecules including VCAM-1, ICAM-1 and E-selectin were induced by TNF-alpha in HUVECs at both the mRNA and protein levels. The mRNA and protein expressions of VCAM-1 and ICAM-1, but not E-selectin, were both significantly suppressed by Tanshinone ILA in a dose dependent manner. In addition, the TNF-alpha-induced mRNA expression of fractalkine/CX3CL1 and the level of soluble fractalkine were both reduced by Tanshinone IIA. We also found that Tanshinone IIA significantly inhibited TNF-alpha-induced nuclear translocation of NF-kappa B which was resulted from the inhibitory effect of Tanshinone IIA on the TNF-alpha-activated phosphorylation of IKK alpha, IKK beta, I kappa B and NF-kappa B. As one of the major components of Salvia miltiorrhiza, Tanshinone IIA alone exerted mote potent effect on inhibiting the adhesion of monocytes to vascular endothelial cells when compared with Salvia miltiorrhiza. All together, these results demonstrate a novel underlying mechanism for the anti-inflammatory effect of Tanshinone IIA by modulating TNF-alpha-induced expression of VCAM-1, ICAM-1 and fractalkine through inhibition of TNF-alpha-induced activation of IKK/NF-kappa B signaling pathway in human vascular endothelial cells. (C) 2013 Elsevier GmbH. All rights reserved.